A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

NCT ID: NCT06028230

This clinical trial is studying a new treatment called SAR444656 for adults with moderate to severe Hidradenitis Suppurativa (HS), a painful skin condition. The trial aims to find out if this treat...

Recruiting

Phase: PHASE2 Type: interventional Locations: Alicante, , Spain, Boynton Beach, Florida, United States +75 more

Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)

NCT ID: NCT06956235

This clinical trial is designed to evaluate a new medication called tulisokibart for people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition that causes bumps and abs...

Recruiting

Phase: PHASE2 Type: interventional Locations: Northridge, California, United States, Birmingham, Alabama, United States +5 more

A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

NCT ID: NCT06468228

This clinical trial is studying a new drug called lutikizumab to see how well it works and how safe it is for treating moderate to severe hidradenitis suppurativa (HS), a painful skin condition tha...

Recruiting

Phase: PHASE3 Type: interventional Locations: Birmingham, Alabama, United States, Phoenix, Arizona, United States +252 more

A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa

NCT ID: NCT06921850

This clinical trial is looking at a medication called bimekizumab to see how it works and how safe it is for children and adolescents with moderate to severe hidradenitis suppurativa (HS). HS is a ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Roseville, California, United States, Clarkston, Michigan, United States +5 more

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

NCT ID: NCT05889182

This clinical trial is studying a medication called upadacitinib to see how effective and safe it is for treating moderate to severe hidradenitis suppurativa (HS) in adults and adolescents who have...

Recruiting

Phase: PHASE3 Type: interventional Locations: Phoenix, Arizona, United States, Fayetteville, Arkansas, United States +381 more

Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients.

NCT ID: NCT06895499

This clinical trial is studying a new treatment called HB0043 for adults with a skin condition known as Hidradenitis Suppurativa (HS). HS causes painful lumps and abscesses in areas like the armpit...

Recruiting

Phase: PHASE1 Type: interventional Locations: Jinan, Shandong, China

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)

NCT ID: NCT06959225

This clinical trial, called TRuE-HS1, is looking at the effectiveness and safety of a cream called ruxolitinib for treating people with hidradenitis suppurativa (HS), a painful skin condition. The ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Alicante, , Spain, Milan, , Italy +107 more

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)

NCT ID: NCT06958211

This clinical trial is studying a new cream called ruxolitinib to see how well it works and how safe it is for people with hidradenitis suppurativa (HS). HS is a chronic skin condition that causes ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Las Palmas De Gran Canaria, , Spain, Birmingham, Alabama, United States +111 more

A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa

NCT ID: NCT06799000

This clinical trial is investigating a new treatment called remibrutinib for adults with moderate to severe hidradenitis suppurativa (HS), a painful skin condition that causes lumps and sores. The ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Norfolk, Virginia, United States, Westmead, New South Wales, Australia +46 more

Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa

NCT ID: NCT06840392

This clinical trial is investigating the effectiveness and safety of a medication called remibrutinib for adults with moderate to severe hidradenitis suppurativa (HS), a skin condition that causes ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Columbus, Ohio, United States, Tampa, Florida, United States +46 more

Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin

NCT ID: NCT05066113

This clinical trial is studying a new treatment called radiofrequency-based selective electrothermolysis, which aims to see how it affects skin health and conditions like Hidradenitis Suppurativa (...

Recruiting

Phase: NA Type: interventional Locations: Baltimore, Maryland, United States

A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)

NCT ID: NCT06685835

This clinical trial is studying a new treatment called brensocatib for adults with moderate to severe Hidradenitis Suppurativa (HS), which is a painful skin condition that causes lumps and abscesse...

Recruiting

Phase: PHASE2 Type: interventional Locations: Baton Rouge, Louisiana, United States, Tampa, Florida, United States +60 more

A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa

NCT ID: NCT06603077

This clinical trial is investigating a new treatment called AVTX-009 for patients with moderate to severe Hidradenitis Suppurativa (HS), a skin condition that causes painful lumps and sores. The go...

Recruiting

Phase: PHASE2 Type: interventional Locations: Savannah, Georgia, United States, Ft. Gratiot, Michigan, United States +69 more

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

NCT ID: NCT06888193

This clinical trial is studying how much of the medication bimekizumab appears in the breast milk of mothers who are being treated for conditions like moderate to severe plaque psoriasis, psoriatic...

Recruiting

Phase: PHASE1 Type: interventional Locations: Calgary, , Canada

Hidradenitis - an Analysis of Genetic Traits and Linkages in Families

NCT ID: NCT05710393

This clinical trial is studying Hidradenitis Suppurativa (HS), a skin condition that causes painful lumps and sores. The researchers want to find out if there are genetic links or traits that conne...

Recruiting

Type: observational Locations: Chicago, Illinois, United States

A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

NCT ID: NCT06046729

This clinical trial is studying a new treatment called eltrekibart for adults who have moderate to severe hidradenitis suppurativa (HS), a skin condition that causes painful lumps and abscesses. Th...

Recruiting

Phase: PHASE2 Type: interventional Locations: Durham, North Carolina, United States, Milwaukee, Wisconsin, United States +89 more

A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa

NCT ID: NCT07007637

This clinical trial is designed to evaluate the long-term safety, tolerability, and effectiveness of a medication called sonelokimab for people with moderate to severe hidradenitis suppurativa (HS)...

Not yet recruiting

Phase: PHASE3 Type: interventional

Gentian Violet Treatment for Hidradenitis Suppurativa

NCT ID: NCT04388163

This clinical trial is studying how a treatment called gentian violet affects people with a skin condition known as Hidradenitis Suppurativa (HS), which causes painful lumps and sores. The research...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Winston Salem, North Carolina, United States

An Open-label, Time-lagged, Dose-escalation Study to Evalaute the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.

NCT ID: NCT06326476

This clinical trial is examining a new treatment called siplizumab for people with hidradenitis suppurativa (HS), a painful skin condition that causes lumps and abscesses. The study aims to see if ...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Birmingham, Alabama, United States

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

NCT ID: NCT03661866

The TARGET-DERM study is looking at how well current and future treatments work for people with skin conditions like Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasi...

Recruiting

Type: observational Locations: Rochester, Minnesota, United States, Minneapolis, Minnesota, United States +64 more

Main Menu

Clinical Trials for Hidradenitis Suppurativa

60 Active Trials Found

A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)

A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients.

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)

A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa

Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa

Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin

A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)

A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Hidradenitis - an Analysis of Genetic Traits and Linkages in Families

A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa

Gentian Violet Treatment for Hidradenitis Suppurativa

An Open-label, Time-lagged, Dose-escalation Study to Evalaute the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Related Conditions